First Eagle Investment Management, LLC Laboratory Corp Of America Holdings Transaction History

First Eagle Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$167.03 - $201.3 $49.9 Million - $60.1 Million	-298,742 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$113.31 - $182.44 $8.23 Million - $13.3 Million	72,660 Added 32.14%	298,742 $49.6 Million
Q1 2020 May 12, 2020	SELL	$104.32 - $195.28 $168,789 - $315,963	-1,618 Reduced 0.71%	226,082 $28.6 Million
Q4 2019 Feb 10, 2020	BUY	$163.48 - $173.61 $4.05 Million - $4.31 Million	24,800 Added 12.22%	227,700 $38.5 Million
Q3 2019 Nov 12, 2019	BUY	$159.77 - $178.1 $17.8 Million - $19.9 Million	111,500 Added 121.99%	202,900 $34.1 Million
Q2 2019 Aug 13, 2019	BUY	$144.16 - $172.9 $13.2 Million - $15.8 Million	91,400 New	91,400 $15.8 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.